+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Human Antimicrobial Susceptibility Testing Market Research Report by Type, Product, Method, Application, End User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 124 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5722219
The United States Human Antimicrobial Susceptibility Testing Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Human Antimicrobial Susceptibility Testing Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Human Antimicrobial Susceptibility Testing Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Human Antimicrobial Susceptibility Testing Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Human Antimicrobial Susceptibility Testing Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Human Antimicrobial Susceptibility Testing Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Human Antimicrobial Susceptibility Testing Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market is studied across Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, and Antiparasitic Susceptibility Testing.
  • Based on Product, the market is studied across Automated Laboratory Instruments, Consumables, Culture & Growth Media, and Manual Antimicrobial Susceptibility Testing Products.
  • Based on Method, the market is studied across Agar Dilution, Automated Susceptibility Testing Instruments, Disk Diffusion, Etest Method, and Genotyping Methods.
  • Based on Application, the market is studied across Clinical Diagnostics, Drug Discovery & Development, and Epidemiology.
  • Based on End User, the market is studied across Contract Research Organizations, Hospital & Diagnostic Centers, Pharmaceutical & Biotechnology, and Research & Academic Institutes.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Human Antimicrobial Susceptibility Testing Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Human Antimicrobial Susceptibility Testing Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Human Antimicrobial Susceptibility Testing Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Human Antimicrobial Susceptibility Testing Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Human Antimicrobial Susceptibility Testing Market, including Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Bruker Corporation, Danaher Corporation, Erba Group, Genefluidics, Inc., Himedia Laboratories Private Limited, Liofilchem S.r.l., Mast Group Ltd., Merck KGaA, QuantaMatrix Inc., Resistell AG, Synoptics Group, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Human Antimicrobial Susceptibility Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Human Antimicrobial Susceptibility Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Human Antimicrobial Susceptibility Testing Market?
4. What is the competitive strategic window for opportunities in the United States Human Antimicrobial Susceptibility Testing Market?
5. What are the technology trends and regulatory frameworks in the United States Human Antimicrobial Susceptibility Testing Market?
6. What is the market share of the leading vendors in the United States Human Antimicrobial Susceptibility Testing Market?
7. What modes and strategic moves are considered suitable for entering the United States Human Antimicrobial Susceptibility Testing Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of infectious diseases in the U.S.
5.1.1.2. Government initiatives to reduce the burden of infectious diseases
5.1.2. Restraints
5.1.2.1. High cost of human antimicrobial susceptibility testing
5.1.3. Opportunities
5.1.3.1. Advancements in human antimicrobial susceptibility testing equipments
5.1.4. Challenges
5.1.4.1. Time consuming testing procedure
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Human Antimicrobial Susceptibility Testing Market, by Type
6.1. Introduction
6.2. Antibacterial Susceptibility Testing
6.3. Antifungal Susceptibility Testing
6.4. Antiparasitic Susceptibility Testing

7. Human Antimicrobial Susceptibility Testing Market, by Product
7.1. Introduction
7.2. Automated Laboratory Instruments
7.3. Consumables
7.4. Culture & Growth Media
7.5. Manual Antimicrobial Susceptibility Testing Products

8. Human Antimicrobial Susceptibility Testing Market, by Method
8.1. Introduction
8.2. Agar Dilution
8.3. Automated Susceptibility Testing Instruments
8.4. Disk Diffusion
8.5. Etest Method
8.6. Genotyping Methods

9. Human Antimicrobial Susceptibility Testing Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics
9.3. Drug Discovery & Development
9.4. Epidemiology

10. Human Antimicrobial Susceptibility Testing Market, by End User
10.1. Introduction
10.2. Contract Research Organizations
10.3. Hospital & Diagnostic Centers
10.4. Pharmaceutical & Biotechnology
10.5. Research & Academic Institutes

11. California Human Antimicrobial Susceptibility Testing Market
11.1. Introduction

12. Florida Human Antimicrobial Susceptibility Testing Market
12.1. Introduction

13. Illinois Human Antimicrobial Susceptibility Testing Market
13.1. Introduction

14. New York Human Antimicrobial Susceptibility Testing Market
14.1. Introduction

15. Ohio Human Antimicrobial Susceptibility Testing Market
15.1. Introduction

16. Pennsylvania Human Antimicrobial Susceptibility Testing Market
16.1. Introduction

17. Texas Human Antimicrobial Susceptibility Testing Market
17.1. Introduction

18. Competitive Landscape
18.1. FPNV Positioning Matrix
18.1.1. Quadrants
18.1.2. Business Strategy
18.1.3. Product Satisfaction
18.2. Market Ranking Analysis, By Key Player
18.3. Market Share Analysis, By Key Player
18.4. Product Portfolio Analysis, By Key Player
18.5. Competitive Scenario
18.5.1. Merger & Acquisition
18.5.2. Agreement, Collaboration, & Partnership
18.5.3. New Product Launch & Enhancement
18.5.4. Investment & Funding
18.5.5. Award, Recognition, & Expansion

19. Company Usability Profiles
19.1. Accelerate Diagnostics, Inc.
19.2. Becton, Dickinson and Company
19.3. Bio-Rad Laboratories, Inc.
19.4. bioMérieux SA
19.5. Bruker Corporation
19.6. Danaher Corporation
19.7. Erba Group
19.8. Genefluidics, Inc.
19.9. Himedia Laboratories Private Limited
19.10. Liofilchem S.r.l.
19.11. Mast Group Ltd.
19.12. Merck KGaA
19.13. QuantaMatrix Inc.
19.14. Resistell AG
19.15. Synoptics Group
19.16. Thermo Fisher Scientific Inc.

20. Appendix
20.1. Discussion Guide
20.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DYNAMICS
FIGURE 8. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
FIGURE 12. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIBACTERIAL SUSCEPTIBILITY TESTING, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIFUNGAL SUSCEPTIBILITY TESTING, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIPARASITIC SUSCEPTIBILITY TESTING, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 18. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED LABORATORY INSTRUMENTS, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CULTURE & GROWTH MEDIA, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
FIGURE 23. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 24. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY METHOD, 2030
FIGURE 25. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AGAR DILUTION, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SUSCEPTIBILITY TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DISK DIFFUSION, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ETEST METHOD, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GENOTYPING METHODS, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 31. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 32. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 33. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
FIGURE 34. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
FIGURE 35. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY EPIDEMIOLOGY, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 37. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 38. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2030
FIGURE 39. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
FIGURE 40. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
FIGURE 41. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
FIGURE 42. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
FIGURE 43. CALIFORNIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. FLORIDA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. ILLINOIS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. NEW YORK HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. OHIO HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. PENNSYLVANIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. TEXAS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 51. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 52. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIBACTERIAL SUSCEPTIBILITY TESTING, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIBACTERIAL SUSCEPTIBILITY TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIFUNGAL SUSCEPTIBILITY TESTING, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIFUNGAL SUSCEPTIBILITY TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIPARASITIC SUSCEPTIBILITY TESTING, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIPARASITIC SUSCEPTIBILITY TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED LABORATORY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED LABORATORY INSTRUMENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONSUMABLES, BY STATE, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CULTURE & GROWTH MEDIA, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CULTURE & GROWTH MEDIA, BY STATE, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AGAR DILUTION, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AGAR DILUTION, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SUSCEPTIBILITY TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SUSCEPTIBILITY TESTING INSTRUMENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DISK DIFFUSION, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DISK DIFFUSION, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ETEST METHOD, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ETEST METHOD, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GENOTYPING METHODS, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GENOTYPING METHODS, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY EPIDEMIOLOGY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY EPIDEMIOLOGY, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. CALIFORNIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 49. CALIFORNIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. CALIFORNIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. CALIFORNIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 52. CALIFORNIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. CALIFORNIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. FLORIDA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 55. FLORIDA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. FLORIDA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. FLORIDA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 58. FLORIDA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. FLORIDA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. ILLINOIS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 61. ILLINOIS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. ILLINOIS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. ILLINOIS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 64. ILLINOIS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. ILLINOIS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. NEW YORK HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 67. NEW YORK HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. NEW YORK HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. NEW YORK HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 70. NEW YORK HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. NEW YORK HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. OHIO HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 73. OHIO HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. OHIO HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. OHIO HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 76. OHIO HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. OHIO HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. PENNSYLVANIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 79. PENNSYLVANIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. PENNSYLVANIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. PENNSYLVANIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 82. PENNSYLVANIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. PENNSYLVANIA HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. TEXAS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 85. TEXAS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. TEXAS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. TEXAS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 88. TEXAS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. TEXAS HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 91. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 92. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 93. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET RANKING, BY KEY PLAYER, 2022
TABLE 94. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 95. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 96. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET MERGER & ACQUISITION
TABLE 97. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 98. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 99. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET INVESTMENT & FUNDING
TABLE 100. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 101. UNITED STATES HUMAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: LICENSE & PRICING

Companies Mentioned

  • Accelerate Diagnostics, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Bruker Corporation
  • Danaher Corporation
  • Erba Group
  • Genefluidics, Inc.
  • Himedia Laboratories Private Limited
  • Liofilchem S.r.l.
  • Mast Group Ltd.
  • Merck KGaA
  • QuantaMatrix Inc.
  • Resistell AG
  • Synoptics Group
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...